AstraZeneca ceo warns of medicine shortages after Brexit - Sunday Times
LONDON, Sept 22 (Reuters) - Britain could see widespread
medicine shortages if there is no deal to prevent friction at
the border with the European Union after Brexit, the AstraZeneca
chief executive told the Sunday Times.
The company said in July it would stockpile drugs as a
Brexit safety net, and CEO Pascal Soriot told the Sunday Times
in an interview that the complexity of the supply chain in
pharmaceuticals meant that delays would be likely.
"We have products that go back and forth between the UK and
Europe at different stages of manufacturing," he was quoted as
saying. "If drugs are stuck, you have a problem."
Separately, the Sunday Times reported that Jaguar Land Rover
was considering following BMW's lead and bringing forward its
annual summer factory shutdown to coincide with Britain's
departure from the EU in case there is no deal, but added no
decision had been taken.
(Reporting by Alistair Smout;
Editing by Sandra Maler)
© 2018 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.